TipRanks
Go Ultimate55% OFF

Epigenomics (ECX) Q3 2020 Earnings Report

DE:ECX Q3 2020 EPS Results

Actual EPS
-EUR 9.17
Consensus EPS
―
Beat/Miss
―
One Year Ago EPS
-EUR 10.98

DE:ECX Q3 2020 Revenue Results

Actual Revenue
EUR 219.00K
Expected Revenue
―
Beat/Miss
―
YoY Revenue Growth
+30.36%

Earnings Announcement Details

Quarter
Q3 2020
Date
11/12/2020
Time
Before Open
Conference Call
Thursday, November 12, 2020

Q3 2020 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q3 2020 Earnings Slide Deck

No slide deck is available for this earnings event.

Q3 2020 Earnings Call Summary

No earnings call summary is available for this earnings event.

DE:ECX Earnings History

DE:ECX earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Aug 12, 20262026 (Q2)―-0.14-0.2337.28% (+0.09)
Aug 06, 20252025 (Q2)―-0.23-0.9174.40% (+0.68)
May 07, 20252025 (Q1)―-2.92――
Mar 20, 20252024 (Q4)―-――
Nov 06, 20242024 (Q3)―-――
Jul 22, 20242024 (Q2)―-0.89-3.0370.53% (+2.14)
May 08, 20242024 (Q1)―-――
Mar 14, 20242023 (Q4)―--7.95―
Nov 09, 20232023 (Q3)―--0.1―
Aug 10, 20232023 (Q2)―-3.03-1.56-93.98% (-1.47)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed
Show More